Abvc Biopharma, Inc.
ABVC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001173313
No open-market purchases or sales by Abvc Biopharma, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.72M in total; no superinvestor holds it.
Other share classesECOC
Q2 2026 vs. Q1 2026
How the institutions holding Abvc Biopharma, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 13 | 15 | +2 |
| Shares | 816.5K | 1.09M | +273.3K (+33.5%) |
| Value | $792.1K | $1.72M | +$929.9K (+117.4%) |
New holders (7)
Institutions that held Abvc Biopharma, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 72,091 | $113.9K | 0.00% |
| XTX Topco Ltd | 48,276 | $76.3K | 0.00% |
| Panagora Asset Management Inc | 36,682 | $58.0K | 0.00% |
| Jane Street Group, LLC | 20,059 | $31.7K | 0.00% |
| Citigroup Inc | 540 | $853 | 0.00% |
| LifeSteps Financial, Inc. | 300 | $474 | 0.00% |
| Caitong International Asset Management Co., Ltd | 6 | $9 | 0.00% |
Sold out (5)
Institutions that held Abvc Biopharma, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Renaissance Technologies LLC | 95,100 | $92.3K |
| Two Sigma Securities, LLC | 21,023 | $20.4K |
| Dimensional Fund Advisors LP | 12,227 | $11.9K |
| Squarepoint Ops LLC | 10,547 | $10.2K |
| Tower Research Capital LLC (TRC) | 5,423 | $5.26K |